Select Page

Assessing HIPAA Risks During the M&A Due Diligence Process

Jon Moore, Chief Risk Officer and Senior Vice President of Consulting Services, Clearwater, speaks with Vanessa Burrows, Counsel, Simpson Thacher & Bartlett LLP, and Wendi Wright, Senior Director of Privacy & Data Protection, Intuitive Surgical, about why HIPAA must be considered within the scope of M&A due diligence and what the diligence process looks like. They discuss documentation, external data sources, the diligence call, and practices to review, such as de-identified Protected Health Information and web tracking technologies. Vanessa and Wendy spoke on an AHLA webinar last year related to this topic. Sponsored by Clearwater.

To learn more about AHLA and the educational resources available to the health law community, visit americanhealthlaw.org.

Related Blogs

Is Cybersecurity Now a Patient Safety Issue?

Is Cybersecurity Now a Patient Safety Issue?

In this episode of SCALE Healthcare's Analyzing Healthcare podcast series, SCALE CEO Roy Bejarano sits down with Clearwater President Baxter Lee to discuss why cybersecurity has become central to healthcare operations, patient care, and enterprise value.
No results found.